Beyfortus 50 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FT167
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,834
Award facts
- Contract value 100% obligated
- $12,834.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,834.16 to AmerisourceBergen Drug Corp for BEYFORTUS 50 mg/0.5 ml syringes on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed price contract is non-competitive and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BEYFORTUS is a monoclonal antibody immunization used for respiratory syncytial virus (RSV) prevention and represents part of the company's broader pharmaceutical supply portfolio supporting federal medical procurement needs.
This delivery order is issued under AmerisourceBergen's SPE2DX indefinite delivery vehicle, a $999,999,999 contract with the DLA running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for the Defense Health Agency and U.S. military healthcare systems. The company's extensive federal contract portfolio demonstrates capability across diverse pharmaceutical product categories, and this RSV immunization delivery reflects the company's continued role as a primary pharmaceutical supplier supporting military medical readiness and healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FT167?
SPE2DR26FT167 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DR26FT167 worth?
The government has obligated $12,834 on SPE2DR26FT167.
Is contract SPE2DR26FT167 an order under another contract?
Yes. SPE2DR26FT167 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT167 competed?
The extent of competition for SPE2DR26FT167 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award